These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8985818)

  • 1. Case report: agranulocytosis induced by interferon-alpha therapy for chronic hepatitis C.
    Higashi Y; Sakai K; Tada S; Miyase S; Nakamura T; Kamio T; Haraguchi O
    J Gastroenterol Hepatol; 1996 Nov; 11(11):1012-5. PubMed ID: 8985818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
    Saracco G; Borghesio E; Mesina P; Solinas A; Spezia C; Macor F; Gallo V; Chiandussi L; Donada C; Donadon V; Spirito F; Mangia A; Andriulli A; Verme G; Rizzetto M
    J Hepatol; 1997 Jul; 27(1):56-62. PubMed ID: 9252074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis].
    Halász T; Farkas A; Tolvaj G; Horváth G
    Orv Hetil; 2006 Feb; 147(7):321-4. PubMed ID: 17489160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment of advanced HCV associated liver disease with interferon and G-CSF.
    Van Thiel DH; Faruki H; Friedlander L; Fagiuoli S; Caraceni P; Molloy PJ; Kania RJ; Wright HI
    Hepatogastroenterology; 1995; 42(6):907-12. PubMed ID: 8847044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.
    Gopal DV; Rabkin JM; Berk BS; Corless CL; Chou S; Olyaei A; Orloff SL; Rosen HR
    Liver Transpl; 2001 Mar; 7(3):181-90. PubMed ID: 11244158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of recombinant interferon-alpha 2b in the treatment of Chinese patients with chronic hepatitis C.
    Hwang SJ; Chan CY; Lu RH; Wu JC; Lee SD
    J Interferon Cytokine Res; 1995 Jul; 15(7):611-6. PubMed ID: 7553231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C.
    Di Marco V; Lo Iacono O; Cammà C; Almasio PL; Vaccaro A; Fuschi P; Giunta M; Fabiano C; Pagliaro L; Craxì A
    J Med Virol; 1997 Jan; 51(1):17-24. PubMed ID: 8986944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon alpha-associated agranulocytosis during clozapine treatment. Case report and status of current knowledge].
    Schäfer M; Schmidt F; Grunze H; Laakmann G; Loeschke K
    Nervenarzt; 2001 Nov; 72(11):872-5. PubMed ID: 11758095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment.
    Kogure T; Ueno Y; Fukushima K; Nagasaki F; Inoue J; Kakazu E; Matsuda Y; Kido O; Nakagome Y; Kimura O; Obara N; Wakui Y; Iwasaki T; Shimosegawa T
    World J Gastroenterol; 2007 Aug; 13(32):4394-7. PubMed ID: 17708618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
    Gill G; Bajwa H; Strouhal P; Buch HN
    J Med Case Rep; 2016 Sep; 10(1):253. PubMed ID: 27632981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term administration of natural interferon-alpha in patients with chronic hepatitis C: relationship to serum RNA concentration, HCV-RNA genotypes, histological changes and hepatitis C virus.
    Kumada T; Nakano S; Takeda I; Sugiyama K; Osada T; Kiriyama S; Toyoda H; Sasa T; Shibata M; Morishima T; Nakano I; Fukuda Y; Kosaka Y; Tameda Y; Nakashima M
    J Gastroenterol Hepatol; 1996 Feb; 11(2):159-65. PubMed ID: 8672762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor as adjuvant therapy for factor as adjuvant therapy for interferon alpha treatment of chronic hepatitis C.
    Carreno V; Parra A; Navas S; Quiroga JA
    Cytokine; 1996 Apr; 8(4):318-22. PubMed ID: 9162222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe agranulocytosis as a rare side effect of pegylated interferon therapy for chronic hepatitis B.
    Zizer E; Bommer M; Barth T; Dikopoulos N
    Z Gastroenterol; 2011 May; 49(5):596-8. PubMed ID: 21557170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation.
    De Vera ME; Smallwood GA; Rosado K; Davis L; Martinez E; Sharma S; Stieber AC; Heffron TG
    Transplantation; 2001 Mar; 71(5):678-86. PubMed ID: 11292302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study.
    Nordøy I; Krarup HB; Bell H; Christensen PB; Elgjo K; von der Lippe B; De Muckadell OS; Maeland A; Ring-Larsen H; Samdal HH; Simmonds P; Skaug K; Tage-Jensen U; Schrumpf E
    Scand J Gastroenterol; 1997 Dec; 32(12):1256-60. PubMed ID: 9438325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive renal failure and blindness due to retinal hemorrhage after interferon therapy for hepatitis C virus-associated membranoproliferative glomerulonephritis.
    Suzuki T; Yonemura K; Miyaji T; Suzuki H; Takahira R; Fujigaki Y; Fujimoto T; Hishida A
    Intern Med; 2001 Aug; 40(8):708-12. PubMed ID: 11518107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
    Martinot M; Marcellin P; Boyer N; Detmer J; Pouteau M; Castelnau C; Degott C; Aupérin A; Collins M; Kolberg J; Wilber J; Benhamou JP; Erlinger S
    Ann Intern Med; 1997 Jun; 126(11):874-81. PubMed ID: 9163288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.